Finance

Lists
Why is NRSN down 28.14%?
Dive Deeper
NRSN:NASDAQ
Neurosense Therapeutics Ltd
$1.43
-28.14%
(-0.56) 1D
$1.43
0.00% (0.00)
Pre-market
Closed: Nov 2, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRSN...
Open
$2.02
High
$2.04
Low
$1.10
Mkt. cap
2.71M
Avg. vol.
24.51K
Volume
362.00
52-wk high
$25.40
52-wk low
$1.10
EPS
-$7.08
Beta
1.66
Shares outstanding
1.90M
No. of employees
17
Open
$2.02
High
$2.04
Low
$1.10
Mkt. cap
2.71M
Avg. vol.
24.51K
Volume
362.00
52-wk high
$25.40
52-wk low
$1.10
EPS
-$7.08
Beta
1.66
Shares outstanding
1.90M
No. of employees
17
News stories
From web sources and news partners
About Neurosense Therapeutics Ltd
CEO-
Employees17
Founded2017
Headquarters-
SectorBiotechnology
Websiteneurosense-tx.com
Analyst ratings
Based on 3 analysts giving stock ratings to NRSN in the past 3 months
Buy
Buy
1
Hold
2
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NRSN in the last 3 months.
Highest
Current $1.43
$180.00 (+12,487.41%)
Average
$91.75 (+6,316.08%)
Lowest
$3.50 (+144.76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lander Egana Gorrono
H.C. Wainwright
Hold
Downgraded
-
-
11/02/2026
Boobalan Pachaiyappan
Roth MKM
Hold
Downgraded
$3.50
+144.8%
10/13/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$180.00
+12,487.4%
08/11/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$7.50
+424.5%
02/19/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.25M
1.25M
1.86M
1.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.09M
1.09M
1.33M
1.33M
Operating expense
2.35M
2.35M
3.20M
3.20M
Total operating expenses
2.35M
2.35M
3.20M
3.20M
Operating income
-2.35M
-2.35M
-3.20M
-3.20M
Other non operating income
-
-
-3.00K
-3.00K
EBT including unusual items
-2.35M
-2.35M
-3.21M
-3.21M
EBT excluding unusual items
-2.35M
-2.35M
-3.21M
-3.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.35M
-2.35M
-3.21M
-3.21M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
15.00K
15.00K
Interest expense
-8.50K
-8.50K
-
-
Net interest expenses
-8.50K
-8.50K
15.00K
15.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.34M
-2.34M
-3.19M
-3.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps